FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068793 [Registered on: 12/06/2024] Trial Registered Prospectively
Last Modified On: 02/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   A clinical trail on kalladaippu kudineer in the management of kalladaippu noi(urolithiasis) 
Scientific Title of Study   A Prospective, open labelled, non randomized, phase II clinical trial on Kalladaippu kudineer in the management of Kalladaippu Noi( Urolithiasis) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  PANDEESWARAN J 
Designation  PG scholar  
Affiliation  Government Siddha Medical College, Palayamkottai  
Address  Op number 10, PG department of Pothu Maruthuvam, Government Siddha Medical College and Hospital, Tiruvananthapuram main road, Palayamkottai Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  9597652976  
Fax    
Email  pandijeganathan1998@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr T KOMALAVALLI ALIAS MEHALA 
Designation  Head of Department 
Affiliation  Government Siddha Medical College and Hospital palayamkottai 
Address  Op number 10,PG department of Pothu Maruthuvam, Government Siddha Medical College and Hospital, Thiruvananthapuram road,Palayamkottai,Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  9788122691  
Fax    
Email  Komalaarumugam1@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr T KOMALAVALLI ALIAS MEHALA 
Designation  Head of Department 
Affiliation  Government Siddha Medical College and Hospital palayamkottai 
Address  Op number 10,PG department of Pothu Maruthuvam Government Siddha Medical College and Hospital, Thiruvananthapuram road,Palayamkottai, Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  9788122691  
Fax    
Email  Komalaarumugam1@gmail.com  
 
Source of Monetary or Material Support  
OPD and IPD facilities and central library of government siddha medical college and hospital, Tiruvananthapuram main road, Palayamkottai,Tirunelveli-627002,Tamilnadu, India  
 
Primary Sponsor  
Name  Government Siddha Medical College and Hospital  
Address  PG department of Pothu Maruthuvam, Government Siddha Medical College and Hospital, Thiruvananthapuram main road, Palayamkottai,Tirunelveli-627002,Tamilnadu, India  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
J Pandeeswaran   Government Siddha Medical College and Hospital   Op number 10,PG department of Pothu Maruthuvam, Government Siddha Medical College and Hospital, Tiruvananthapuram main road, Palayamkottai-627002,India
Tirunelveli
TAMIL NADU 
9597652976

pandijeganathan1998@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical committee,Government Siddha Medical College and Hospital, Palayamkottai   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N20-N23||Urolithiasis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Kalladaippu kudineer  DOSAGE:30-60ml twice a day Orally for 45 days 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Evidence of renal calculus,confirmed by using
2.Renal colicky pain
3.Haematuria
4.Oliguria
5.Dysuria
6.Nausea,vomiting 
 
ExclusionCriteria 
Details  1.Chronic appendicitis
2.Pyelonephritis
3.Recurrent UTI
4.Chronic renal failure
5.Bilateral obstructive uropathy
6.Diabetes mellitus
7.Metabolic disorder like hyperthyroidism, hyperparathyroidism 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The outcome will be aimed at reducing clinical symptoms and calculi size ,will be considered as successful outcome of the treatment  45 days 
 
Secondary Outcome  
Outcome  TimePoints 
1.To collect various siddha and modern journals for literature review on KALLADAIPPU NOI
2.To evaluate the clinical lithotriptic and diuretic pharmacological activities of trail drug
3.To evaluate additional effects and siddha parameters, Envagai thervugal changes in KALLADAIPPU NOI
4.To evaluate the safety profile for acute and sub-acute toxicity of the trail drug
5.To perform biochemical analysis
6.To perform usg abdomen in selected cases
 
6months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   25/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
This is A Prospective, openlabelled, non randomized, phase II clinical trial on Kalladaippu kudineer in the management of Kalladaippu noi (Urolithiasis).After authentication and purification of the Kalladaippu kudineer is prepared and administered at the dosage of 30-60ml (Twice a day orally) for 45 days known renal calculi Patients (40 (IP & OP )patients). The primary outcome will be determining the effectiveness of  Kalladaippu kudineer in the management of Kalladaippu  noi.The secondary outcome will be to collect various siddha literatures and modern science journals,to evaluate the clinical lithotriptic & diuretic pharmacological activities of trial drug,to Evaluate additional effects & Siddha parameters, Envagai thervugal changes in
Kalladaippu noi (Urolithiasis),to evaluate the safety profile for acute & sub acute toxicity of the trial drug,
to Perform Biochemical analysis and to Perform Usg Abdomen in selected cases.
 
Close